Abstract

This paper covers the use and influence of data-driven decision support systems (DSS) on drug management, particularly in the areas of drug exploration and production. The study, which employed a mixed-methods approach, involving literature review, qualitative interviews, quantitative assessments, and case study analysis, reveals the AI, machine learning and big data analytics ability to drive drug discovery and development processes revolution in the pharmaceutical industry. The study shows that handling of DSS allows sound decision making, consequently resulting in improved efficiency, decreased expenses and better innovation throughout the drug development process. Areas like data integration, algorithm robustness, and regulation are identified as the major issues, which offers an insight into the importance of these areas of concern in the effective application of a data-driven approach in pharmaceutical management. Such contrast with the like works underlines the role of our findings as an essential link in the AI-driven healthcare innovations chain. The research provides a foundation for further improving the state of knowledge and understanding of DSS in drug management, guiding future research aiming at expanding conceptual frameworks and designing practical implementations.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call